Polymerase Chain Reaction (PCR) Technologies and Global Markets

Report Highlights

The global PCR products market is expected to grow from nearly $5 billion in 2010 to nearly $8 billion by 2015, at an estimated compound annual growth rate (CAGR) of 9.9% from 2010 to 2015.

Report Scope

The key PCR markets covered in the report are the markets for instruments, reagents, consumables and accessories, software, and services, as well as PCR applications and technologies.

The PCR instruments market includes buffers and deoxynucleotide triphosphates [dNTPs] (buffers, contamination control kits, dNTP mixes), controls and cDNAs, primers (real-time PCR primers, human linkage mapping sets, mouse mapping primers), PCR enzymes and kits (contamination control kits, general PCR, fast PCR, multiplex PCR, wax beads for hot start PCR, high-fidelity PCR kits, and other kits), accessories, reaction plates, adhesive films, and thermal cyclers.

The other markets include reagents and consumables, and other accessories (PCR plates and frames, PCR tubes, PCR sealers, PCR plastics).  The PCR software market includes primer design and sequencing software, PCR analyzer software, integrated software, and others.

The PCR application market includes research (e.g., genetic testing, gene expression, genetic mapping, tissue typing, hybridization probes, DNA sequencing, the Human Genome Project, forensic science, DNA cloning, bioinformatics, and others), diagnosis (a) infectious disease, for example, HIV, tuberculosis, spread of disease organisms, others, (b) cancer, and (c) prenatal diagnosis and genetic abnormalities, and drug discovery.

The PCR technology market includes inverse PCR, in situ PCR, real-time PCR, reverse transcriptase PCR, nested PCR, long PCR, single cell PCR, and others.

Analyst Credentials

Varsha Bhat has more than 5 years experience in market intelligence, business research, strategic consulting, and analytics.  She has experience in the healthcare domain with respect to pharmaceuticals, pharma chemicals and technologies, and the life sciences market.  Varsha has been constantly tracking, authoring, and interacting with top market participants in these domains and has conducted high-level briefings.  She has frequently delivered research services that contain high-level analysis, strategic recommendations, and top business strategies to enhance the market shares of industry players.  She also has extensive experience in training and leading a global research and analytics team and holds a Bachelor of Science degree in biotechnology and an MBA in marketing.